International publication trends and collaboration performance of China in healthcare science and services research by unknown
ORIGINAL RESEARCH ARTICLE Open Access
International publication trends and
collaboration performance of China in
healthcare science and services research
Kai Chen1†, Qiang Yao2*†, Ju Sun2, Zhi-fei He1, Lan Yao1 and Zhi-yong Liu1
Abstract
Background: In recent years, China’s healthcare reforms and related studies have drawn particular global attention.
The main objective of this study is to evaluate quantitatively the publication trends and collaboration performance
of China in healthcare science and services (HSS) research.
Methods: Scientometric methods and visualization technology were used to survey the growth and development
trends of HSS research based on the Web of Science publications during the past 15 years.
Results: China’s international publications on HSS research increased rapidly compared to those of the global HSS
and Chinese scientific studies. Growth trends indicate that collaboration among countries, institutions and authors
has also increased. China’s leading partners were all developed countries, such as the US, the UK, Australia and
Canada, which have contributed to the majority of the joint publications. The academic impact of publications
involving partners from European and American countries was relatively higher than those involving partners from
Asian countries. Prominent institutions were universities that could be primarily classified into two groups, namely,
Mainland China on the one hand and Hong Kong universities and foreign universities on the other. The most
prominent actors were elite institutions, such as Peking University, Fudan University, Chinese University of Hong
Kong, University of Hong Kong. The papers published by the Chinese Ministry of Health had relatively high
academic impact, whereas those published by Mainland China universities alone had a lower academic impact
compared to foreign cooperation papers. Issues related to the Chinese healthcare reform, priority diseases
(e.g., breast cancer, HIV/AIDS, tuberculosis, etc.), health systems performance, quality of life and
measurement tools, aging problems and research methods have been the most popular HSS topics
in China in recent years.
Conclusions: Despite the extensive achievement of the Chinese HSS reforms and research, gaps and
challenges remain to be addressed, including those related to health insurance and the effects of the
evaluation of essential medicine systems, human resources training and allocation in the health sector,
government hospitals reforms and health services systems remodeling. These findings could help scholars
and decision-makers understand the current status and likely future trends of the Chinese HSS research,
and help them select the most appropriate collaboration partners and policies.
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Background
China has enjoyed rapid economic development since
the reform and open policy implementation in 1978.
Accordingly, China’s economic reforms have achieved
significant success. However, the Chinese healthcare
system began to regress in the 1980s, and many prob-
lems have been encountered thereafter. For example,
from 1978 to 2012, China’s GDP increased at a 17.7 %
compounded annual growth rate, whereas its total
healthcare expenditure grew at a somewhat lower 15.7 %
compounded annual growth rate [1]. With the economic
reform initiated in the early 1980s in China, the health-
care system had to adapt to a new economic approach,
namely, shifting from a communal system to market-
driven competition.
Unfortunately, this disorientation caused several prob-
lems in Chinese society. The SARS outbreak in 2003
shocked the country’s leaders, thereby exposing the in-
adequacies in the public health protection system and
demonstrating government negligence that had left the
healthcare system unprepared to deal with its core re-
sponsibilities [2, 3]. Thereafter, the government struggled
to maintain a balance between meeting the people’s
immediate healthcare needs and developing the health-
care systems with a series of healthcare policies and re-
forms [4–6]. For example, after three years of planning,
China unveiled its ambitious healthcare reform plan in
April 2009 by committing an additional CN¥850 billion
(approximately US$125 billion) over a three-year period
with the provisional goal of affordable and equitable
basic healthcare for all by 2020 [3, 7]. Influenced by
health policies and economic investments, healthcare
science and services (HSS) research in China began to
escalate and develop rapidly.
With the increase in HSS research in China, research
collaboration also proliferated in this field. Scientists
benefited from intellectual exchanges with foreign col-
leagues and reduced costs by sharing resources and
technologies with other countries [8]. Apart from im-
proving research capability, international collaboration
may enhance productivity and visibility, although visibil-
ity improvement varies among countries and fields [9].
In recent decades, the robust relationship between col-
laboration and scientific research productivity and
academic impact has been studied and documented by
Lotka [10] and others. In general, collaboration exerts
positive effects on teams’ outputs and abilities, and co-
operative scientific research results have relatively high
academic impact, particularly those related to inter-
national collaboration. For example, the citations of a
paper are partially related to the number of authors,
institutions and countries participating in the paper.
However, the effects depend on the collaboration type
and the partners involved [11–13]. For example, Narin
showed that multiple-institution papers are more highly
cited than single-institution papers, and papers with a
foreign collaborator are more highly cited than domestic
papers [11, 14]. Glänzel demonstrated that the influence
of international collaboration on national citation per-
formance also varies considerably between countries. In
some cases, no quality advantage exists for one or both
partners, such as in certain collaborations among devel-
oping or Eastern European countries [15]. Meanwhile,
the collaboration patterns and influences on research
productivity or academic impact also vary by discipline
[13, 15]. Therefore, understanding the collaboration
characteristics of specific fields could inform the pol-
icies on partners’ selection and research performance
improvements, and could even contribute to economic
development [16, 17].
This study was built on our previous work which
analyzed the global progress and current research trends
on health care sciences and services research [18]. Al-
though the rapid growth and extensive collaboration in
HSS research is observed in theory and practice in
China, the publication trends, collaboration patterns and
their effects on HSS research in this country remain
unclear. Limited attention has also been focused on
which groups of actors are at the center and at the per-
iphery of the collaboration network. The previous study
was a comprehensive scientomentric research from a
global perspectives, while this study focuses on China's
collaboration relationships in HSS research. Both collab-
oration relationship and publication patterns were stud-
ied on multiple levels and from several perspectives.
With the availability of critical data, such as those from
the Web of Science (WoS) of Thomson Reuters, sciento-
metricians have attempted to explore the characteristics
of international collaboration from various perspectives
[9]. Given the importance of Chinese collaboration in
the international context, the current study evaluated
the publication trends, collaboration patterns and
current research trends of Chinese HSS.
Thus, the objectives of this study are as follows: (1) to
study the Chinese HSS publication trends from absolute
and relative perspectives, (2) to explore the collaboration
patterns and identify the core partners and institutions,
and (3) to present the research foci of HSS in China.
The results of this study could provide evidence on the
current status and recent trends of publication and
collaboration in China, as well as indications of this
topic’s popularity and citation performance.
Methods
Data sources
This study was based on the analysis of article-level data
from the online version of the WoS database, which is
owned by Thomson Reuters. WoS is a highly significant
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and frequently employed source database in reviewing
scientific achievements and trends [19, 20]. Therefore,
HSS-related articles from WoS were suitable for the
present study. Data in this study were acquired on
February 2, 2015 using the following search strategy:
SU =Health Care Sciences & Services AND CU=China
AND PY = 2000–2014. A total of 2416 related papers
were extracted from the databases. Thereafter, the
bibliographies were downloaded and imported into a
bibliographic software program. The Health Care
Sciences & Services subject contains healthcare sci-
ence, healthcare services and health policy-relevant
research within the WoS database.
Analysis Methods
Scientometric methods have been extensively used re-
cently to analyze scientific productions, collaborations
and research topics [19, 21–29]. Scientometric and re-
lated indicators are also suitable for scientific literature
analysis from both the macro- and micro-perspectives.
In the present study, the performance of the publication
and collaboration of HSS research in China is analyzed
from both the quantity and academic impact perspec-
tives. Quantity was determined by the number of publi-
cations and the growth trends were measured through
two related parameters, namely, relative growth rate
(RGR) and doubling time (Dt) [30]. The academic
impact of the papers was measured using the total local
citation score (TLCS), total global citation score (TGCS),
and average global citation score (AGCS) [31]. Co-
authorship and social network analysis were also used to
study the collaboration at the country and institution
levels [18]. Furthermore, co-words and cluster analysis
were used in combination to identify the popular topics.
Visualization technology, particularly knowledge map-
ping technology, was also used to show the results of the
collaboration between countries or institutions and
popular research topics. Thomson Data Analyzer (TDA)
[32] and HistCite [33] were used as statistical analysis
tools. The drawing tools used in this study include
Ucinet [34] and VOSviewer [35].
Growth speed indicators
RGR is originally sourced from the study of financial
investment and is effectively applied in botany to analyze
the growth of individual plants [36]. In the current
study, RGR was used to measure the growth rate of the
number of articles with time. Meanwhile, Dt is dir-
ectly related to RGR and is the time required for the
number of articles to double [26, 29, 37]. RGR and
Dt are defined as follows:RGR = (lnN2 ‐ lnN2)/(t2 − t1)
(Formula 1) Dt = (t2 − t1) * ln2/(lnN2 − ln N1) (Formula
2),where N2 and N1 are the cumulative publications in
two years, that is, t2 and t1, respectively. In the present
analysis, t2 − t1 is considered 1 year. Thereafter, RGR and
Dt can be expressed as RGR = ln (N2/N1) and Dt = In2/
RGR. A constant value for RGR in each subsequent year is
an indication that the growth rate is exponential. Dt is a
characteristic time for this exponential growth.
Academic impact indicators
The academic impact indicators used in this study include
TLCS, TGCS and AGCS based on citation frequency.
TLCS is the number of times that papers in a set included
in a collection has been cited by other papers within the
collection. TGCS is the number of times that papers in a
set included in a collection has been cited in the WoS
database. AGCS is the mean value of TGCS and indicates
the average citation number of articles in the HSS areas.
TLCS and TGCS have been the key indicators in evaluat-
ing the relevance of research papers [18].
Collaboration performance indicators
The term “co-authorship” is often used to denote
multiple authors, institutions or countries appearing
simultaneously in one paper; in this article, they are
called co-authors, co-institutions and co-nations, respect-
ively. Meanwhile, social network analysis (SNA) and the
related centrality indicators were also used to analyze the
collaboration performance of institutions and countries.
As a “structural analysis” method, SNA has been success-
fully applied in various fields, such as sociology, informa-
tion and library sciences, geography and other areas [38].
SNA has also been extensively used to investigate scien-
tific collaboration networks and the relationship between
individuals at the author, institution and country levels
[17, 39, 40]. The current study analyzes trends in the
extent of collaboration at all levels and the collaboration
networks at the country and institution levels, because
country and institution collaboration can reveal the
collaboration at the macro- and meso-levels, respectively.
The combination of the two levels can facilitate further
understanding of trends, networks and core groups of
international collaboration [41]. In the present study, net-
work nodes represent institutions or countries, whereas
ties represent the cooperation of institutions or countries.
Degree centrality is defined as the number of ties of a
node, representing the simplest notion of centrality be-
cause such a value simply refers to the number of neigh-
bors of a node in the network. Degree centrality is a
crucial indicator in analyzing the network, thereby reflect-
ing the importance and influence of an institution or a
country in the network [18].
Results
Growth trends from multiple perspectives
Table 1 shows the year-wise publications of the world
and China in the HSS area, as well as those of China in
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all fields, including the year number, cumulative number,
RGR and Dt from 2000 to 2014.
Absolute perspective
Table 1 presents the number of papers on HSS in China
and in the world from 2000 to 2014. During the past
two decades, the number of published papers related to
HSS increased from 37 in 2000 to above 500 in 2014.
Table 1 also shows that only a few papers were produced
before 2005, which was the formative stage of the
Chinese HSS research. From 2005 to 2010, which was
the development stage of Chinese HSS research, the
annual output of papers did not exceed 200. Thereafter,
the number of papers increased rapidly (i.e., after 2010),
when the Chinese HSS research entered the rapid devel-
opment stage. Nevertheless, the inflection point of
maturity, where growth begins to taper off, has not yet
been reached.
Relative perspective
Figures 1 and 2 show the Chinese HSS papers as a
percentage of Chinese papers in all fields and the world
HSS papers. The percentage of Chinese HSS papers
reveals the publication trends from a relative perspec-
tive, which can precisely and relatively reflect the devel-
opment trends of Chinese HSS research. The percentage
of Chinese HSS papers exhibited up and down trends,
thereby implying a decrease and a rapid increase,
respectively, before and after 2005. The increasing stage
could be divided into two stages, namely, constant
growth (2005–2010) and fluctuant growth (2010–2014)
stages. These results are considered based on the publica-
tion trends, thereby suggesting that Chinese researchers
focused considerable attention and effort to HSS studies
compared to other fields in China and to HSS research in
the world.
Dynamic perspective
The growth perspective indicates that the average values
of worldwide RGR and Dt were 0.29 and 2.95, respect-
ively. The average values of RGR and Dt for the Chinese
HSS research were 0.30 and 2.66, respectively (Table 1).
Meanwhile, the average values of RGR and Dt for all
fields in China were 0.15 and 4.89. In the HSS field, the
global growth rate showed a significant decrease during
the last 15 years. Meanwhile, China revealed up and

























2000 37 37 7730 7730 31953 31953 — — — — — —
2001 43 80 6814 14544 37407 69360 0.77 0.78 0.16 0.90 0.89 4.40
2002 48 128 8235 22779 42316 111676 0.47 0.48 0.12 1.47 1.46 5.62
2003 55 183 8903 31682 51843 163519 0.36 0.38 0.20 1.94 1.82 3.41
2004 63 246 9162 40844 65036 228555 0.30 0.33 0.23 2.34 2.07 3.06
2005 54 300 9949 50793 76268 304823 0.20 0.29 0.16 3.49 2.41 4.35
2006 69 369 10920 61713 92630 397453 0.21 0.27 0.19 3.35 2.61 3.57
2007 87 456 11570 73283 100981 498434 0.21 0.23 0.09 3.27 3.06 8.03
2008 124 580 12775 86058 117710 616144 0.24 0.21 0.15 2.88 3.27 4.52
2009 159 739 14272 100330 134307 750451 0.24 0.20 0.13 2.86 3.52 5.25
2010 223 962 14618 114948 149457 899908 0.26 0.18 0.11 2.63 3.82 6.49
2011 228 1190 15921 130869 173125 1073033 0.21 0.18 0.15 3.26 3.94 4.72
2012 351 1541 18337 149206 199132 1272165 0.26 0.17 0.14 2.68 4.07 4.95
2013 348 1889 19317 168523 236653 1508818 0.20 0.17 0.17 3.40 4.06 4.02
2014 527 2416 19307 187830 264943 1773761 0.25 0.16 0.11 2.82 4.28 6.14
No. of China: number of articles published by China on HSS; No. of World: number of articles published by the world on HSS; No. of China all: number of articles
published by China on all fields
Fig. 1 Chinese HSS papers as a percentage of Chinese papers in
all fields
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down trends that indicate a decrease during the first
5 years (from 2001 to 2005), which was a constant trend
after 2005 and a trend exceeding that of the world in
2008. The growth rates of HSS research in both China
and the world were higher than those of all fields in
China. In addition, the growth rate of HSS research in
China showed an impressive increase of 21 % during the
last 15 years. This figure was significantly higher than
that of HSS research in the world (7 %) and of all fields
in China (16 %).
Collaboration and performance
Collaboration trends
Chinese collaboration with other countries in HSS research
exhibits up and down trends; however, the general tendency
of the trends is to increase, particularly after 2003. Figure 3
shows the percentage of collaborative papers, including
those involving co-authors, co-institutions or co-countries.
The percentage of co-authored papers increased from 68 %
in 2000 to 95 % in 2014. The percentages of co-institutional
papers and co-national papers showed increasing trends
from 41 to 67 % and from 27 to 43 %, respectively. These
results suggest that the collaboration between institutions
and countries has increased significantly since 2003.
Figure 4 shows the trends of the average number of
authors, institutions or countries per paper. The average
number of authors per paper increased from 2.73 in
2000 to 5.16 in 2014, whereas the average number of
countries per paper only increased from 1.46 in 2000 to
1.64 in 2014. More than half of the papers are the result
of the cooperation within China; hence, these papers
have an average of approximately two institutions and
four to five authors.
Partner Countries
In terms of quantity, China collaborated with 84 coun-
tries in HSS research over the last 15 years. Among
China’s partners, the US played a major role, accounting
for approximately one-fourth of the Chinese joint publi-
cations in HSS. The UK, the second largest partner of
China, was left significantly behind. Australia and
Canada were also important partners of China. Overall,
China’s top 10 partners contributed to more than half of
the joint publications. In terms of academic impact,
collaborations with the US has the highest TGCS be-
cause of the numerous papers published, followed by
collaborations with the UK, Australia and Canada. The
AGCS of countries are listed in descending order and
includes those of the Netherlands, Switzerland, the UK
and Japan, among others. Papers from China which were
written in collaboration with these countries often have
considerably high academic impact and influence (Table 2).
The collaboration relationships among a core group of
countries (top 30) were visualized using Ucinet, which
allowed for a number of analytical procedures to be
undertaken to determine the types of shared relation-
ships among the countries or regions [42]. Fig. 5 pre-
sents the national or regional cooperative relationship
with China in HSS research. In this figure, the size of
the nodes stands for the centrality degree of a specific
Fig. 2 Chinese HSS papers as a percentage of the world HSS papers
Fig. 3 Percentage of multi-entity in Chinese HSS papers from 2000 to 2014
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country (i.e. the extent to which it is involved in HSS
publications related to China), whereas the thickness of
the links stands for the collaboration strength between
countries. China is located at the core position in the
network and cooperates frequently with the US, the UK,
Australia, Canada, Germany, Netherlands, Switzerland
and Japan, among others. Meanwhile, Taiwan, Singapore
and other countries are located at the periphery. This
situation means that China’s cooperation with this sec-
ond group of countries in studying HSS research is not
as frequent as that with the first group. Other countries
or regions located in the outermost loci of the cooper-
ation network cooperate less with China in this area.
Prominent institutions
One thousand seven hundred eighty-nine institutions
contributed to the set of publications considered in this
study. Table 3 shows the top 20 institutions, each of
which has published over 30 papers, and which together
account for over two-thirds of all publications. The
Chinese University of Hong Kong (CUHK) performed
extremely well and significantly exceeded other institu-
tions with a total of 333 papers published. This finding
suggests that CUHK is the most prominent institution
in terms of HSS research among Chinese institutions.
CUHK is followed by the University of Hong Kong, Peking
University, Fudan University and other universities. Among
non-academic institutions, China’s Ministry of Health had
the highest citations per paper and substantially exceeded
other institutions. This ministry is followed by Harvard
University, Wayne State University and Shandong
University. Meanwhile, CUHK, University of Hong
Kong, Chinese Centre for Disease Control and Prev-
ention (CDC), and Prince Wales Hospital also had
relatively high AGCSs. The AGCSs of articles pub-
lished solely by researchers from Mainland China’s
institutions were relatively low, thereby indicating that
the articles produced in cooperation with foreign
Fig. 4 Average number of different entities per paper in Chinese HSS papers from 2000 to 2014
Table 2 Top 10 productive partners of China in healthcare science and services, 2000-2014
Rank Partner Joint Publications Percent Recs 1st Percent 1st TLCS TGCS AGCS
1 US 566 23.43 265 46.82 316 3477 6.14
2 UK 172 7.12 58 33.72 124 1523 8.85
3 Australia 149 6.17 51 34.23 63 898 6.03
4 Canada 84 3.48 31 36.90 40 653 7.77
5 Singapore 53 2.19 21 39.62 9 163 3.08
6 Taiwan 46 1.90 23 50.00 2 143 3.11
7 Japan 45 1.86 15 33.33 20 378 8.40
8 Switzerland 45 1.86 12 26.67 34 459 10.20
9 The Netherlands 38 1.57 10 26.32 5 418 11.00
10 Germany 35 1.45 10 28.57 3 159 4.54
Joint Publications: number of articles collaborated with China; Percent: percentage of articles; Recs 1st: number of articles collaborated with China as first country;
Percent 1st: percentage of articles collaborated with China as first country; TLCS: Total Local Citation Score, which is the number of times cited by other papers in
the local collection; TGCS: Total Global Citation Score, which is the citation frequency based on the full WoS count at the time the data were downloaded; AGCS is
the average citation frequency of an article
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institutions, particularly the prominent ones, have
relatively high academic impact.
Figure 6 represents the mapping of the top 30 institu-
tions involved in the cooperation of the network in HSS
research with China. Chinese Peking University, Fudan
University and University of Hong Kong are evidently in
the core of the network, thereby indicating that these
institutions cooperate with considerable frequency with
other academic institutions. This finding also means that
these institutions play a significant role in the process of
HSS knowledge transfer on a global scale. Meanwhile,
the entire network can be divided into two institutional
groups of cooperation. One group mainly comprises
institutions in Mainland China, such as Peking Univer-
sity, Fudan University, Huazhong University of Science
and Technology, Shandong University, Sun Yat Sen
University and the Chinese CDC, among others. The
other group primarily comprises various Hong Kong
institutions, such as CUHK, University of Hong Kong,
Hong Kong Polytechnic University, Hong Kong Baptist
University, City University of Hong Kong, Hong Kong
Institute of Education; and a few foreign institutions,
such as Harvard University and National University of
Singapore.
Research topics
The authors’ keywords could offer information on how
the authors conceptualize their own research, and such
keywords have been proven vital in monitoring the
development of science [43–45]. Therefore, the papers’
topics can be observed from the authors’ keywords
through cluster analysis. The 55 authors’ keywords are
divided into four groups that represent popular research
topics on HSS research in China (Fig. 7).
Group 1 (red) – Chinese health topics, including health-
care reform-related topics (e.g., health insurance, primary
care, rural health, hospital problems), priority diseases or
public health problems, health systems performance and
Chinese cultural questions for health, are included in this
group. In the past decades, healthcare reforms were the
Fig. 5 National collaboration map of China in HSS research (The size of the nodes represents the degree centrality of the countries, and the
thickness of the lines represents the co-occurrence frequency between countries)
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major issues in China. Various policies adopted by health
policymakers indicate that China’s healthcare system
reform passed through three periods [46] and nu-
merous milestone events also happened during these
periods [3–5, 7] (For details, see Appendix 1). Mean-
while, setting the priority areas and evaluating the
effects of health reform are two vital topics in the
health reform process. Accordingly, it is not surp-
rising that articles on topics related to the Chinese
health care reform figure prominently among Chinese
HSS publications.
The analysis also indicates that Chinese HSS publica-
tions also focus on specific diseases and health issues,
such as breast cancer, mental health, HIV/AIDS, tuber-
culosis, schistosomiasis and condom use, among others.
Furthermore, healthcare system performance assessment
is an important tool used to evaluate the effects and
performance of healthcare reforms. To monitor and
evaluate the reforms effects or health system status, the
Chinese government and its universities have done a lot
of research on health systems performance assessments.
As showing in Fig. 7, Chinese healthcare systems may be
evaluated from the aspects of health equity, health
access, health cost effectiveness, patient satisfaction and
other aspects.
Group 2 (green) – Quality of life (QOL)-related topics,
such as the measurement of QOL or health-related qual-
ity of life, QOL measurement tools and reliability and
validity of the QOL measurement tools, are included in
this group. The QOL outcomes are significant topics in
HSS research. The World Health Organization (WHO)
defines QOL as an “individual’s perception of their
position in life in the context of the culture and value
systems in which they live and in relation to their goals,
expectations, standards and concerns” [47]. Economic
development has led the Chinese to focus considerable
attention on QOL. Therefore, QOL is a crucial research
topic in China, particularly in recent years. Chinese
researchers mainly focus on developing or improving the
measurement tools based on the world’s popular tools
and Chinese situations, such as SF-36, SF-12, SF-6D,
WHOQOL and EQ-5D [48]. Researchers often use
reliability and validity indicators to evaluate the effects
of the developed or modified tools. Thereafter, they can
measure and understand the Chinese’s QOL and even
compare it with that of people from other countries.
QOL research mainly focuses on children and the aging
population [49, 50]. Significant attention has also been
focused on QOL of patients with cancer, schizophrenia
and depression [51, 52].
Table 3 Top 20 productive institutions with China in healthcare science and services, 2000-2014
No. Institution Recs Percent Recs 1st Percent 1st TLCS TGCS AGCS
1 Chinese Univ Hong Kong 333 13.78 260 78.08 144 2537 7.62
2 Univ Hong Kong 255 10.55 195 76.47 154 1938 7.60
3 Peking Univ 222 9.19 119 53.60 91 1005 4.53
4 Fudan Univ 156 6.46 103 66.03 63 731 4.69
5 Sichuan Univ 81 3.35 54 66.67 14 235 2.90
6 Hong Kong Polytech Univ 79 3.27 55 69.62 24 392 4.96
7 Zhejiang Univ 78 3.23 57 73.08 16 139 1.78
8 Huazhong Univ Sci & Technol 57 2.36 43 75.44 30 200 3.50
9 Sun Yat Sen Univ 56 2.32 28 50.00 23 247 4.41
10 Shandong Univ 47 1.95 26 55.32 78 385 8.19
11 Chinese Ctr Dis Control & Prevent 45 1.86 29 64.44 21 334 7.42
12 Shanghai Jiao Tong Univ 44 1.82 26 59.09 23 203 4.61
13 Wayne State Univ 39 1.61 15 38.46 48 345 8.85
14 Minist Hlth 38 1.57 8 21.05 90 569 14.97
15 Prince Wales Hosp 37 1.53 9 24.32 23 259 7.00
16 Xi An Jiao Tong Univ 36 1.49 23 63.89 7 76 2.11
17 Second Mil Med Univ 35 1.45 29 82.86 11 134 3.83
18 Harvard Univ 34 1.41 7 20.59 54 339 9.97
19 Nanjing Med Univ 34 1.41 18 52.94 9 134 3.94
20 Natl Univ Singapore 34 1.41 14 41.18 9 109 3.21
Recs: number of articles; Percent: percentage of articles; Recs 1st: number of articles as first institution; Percent 1st: percentage of articles as first institution; TLCS:
Total Local Citation Score, which is the number of times cited by other papers in the local collection; TGCS: Total Global Citation Score, which is the citation
frequency based on the full WoS count at the time the data were downloaded; AGCS is the average citation frequency of an article
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Group 3 (blue) – Topics related to the elderly, includ-
ing palliative or end-of-life care and medical education
and methods, are included in this group. Hong Kong
researchers devote significant attention to the problems
of old people, such as old people’s QOL, disability trends
[53], lifestyle risk factors [54], willingness to pay for
specific primary care and preventive services [55], and
others. Mainland China and Hong Kong closely cooper-
ate in the area of palliative or end-of-life care. Palliative
care provides relief from pain and distressing symptoms,
as well as offers psychological and spiritual support to
enhance patients’ QOL. Meanwhile, the needs, current
knowledge and attitudes of old people who come from
staffed homes in Hong Kong are marked differently [56].
Studies in Hong Kong determined that cancer pa-
tients have a relatively high level of palliative care,
which has played a role in improving end-of-life can-
cer care in this city [57, 58]. Developing palliative
care for end-stage diseases has also attracted the
attention of Hong Kong researchers [59]. Both Main-
land China and Hong Kong attach importance to
medical education, as observed in the new medical
curriculum evaluation [60], evidence-based medicine
practice, barriers identification and teaching/learning
assessment [61, 62].
Group 4 (yellow) – Research methods, including sys-
tematic review, meta-analysis and randomized controlled
trial, are included in this group. Systematic review and
meta-analysis have been extensively used by Chinese
researchers in HSS. Moreover, an increasing number of
Chinese researchers tend to use these methods to write
articles because of their advantage in publishing science
citation index/social sciences citation index (SCI/SSCI)
articles. Several researchers also devote attention to the
bias in meta-analysis and attempt to test and modify this
method [63, 64].
Fig. 6 Institutional collaboration map of China in HSS research (The size of the nodes represents the degree centrality of the institutions, and the
thickness of the lines represents the co-occurrence frequency between institutions)
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Discussion
Good performance and bright future from multiple
growth perspectives
China has performed well in the HSS field, thereby in-
dicating a continuously rising trend that has increased
exponentially in the last 15 years. The growth rate of
HSS research in China is significantly faster than that
of HSS research in the world and of other fields in
China. Recent trends in Chinese HSS research generally
suggest a bright future in terms of quantity compared
to the HSS research in the world and with other fields
in China.
Many factors may have contributed to the rapid
growth of international Chinese publications in the HSS
fields, such as health policies and reforms, health projects
and funds, international collaboration, research evaluation
policies or mechanisms, graduate student enrolment ex-
pansion and other factors. First, the Chinese healthcare re-
forms in the HSS field commenced in the 1980s and
China has undergone three reform periods [46]. Mean-
while, numerous milestone events occurred during these
periods. In 2006, health officials and decision-makers real-
ized that the previous reforms were unsuccessful; thus, a
new round of reforms began [4, 5]. In April 2009, after
three years of planning, China unveiled its ambitious
healthcare reform plan by committing to invest an
additional CN¥850 billion (approximately US$125 billion)
over a three-year period with the provisional goal of
providing affordable and equitable basic health care for all
by 2020 [3, 7]. Therefore, these remarkable events have
been highly considered by scholars and healthcare institu-
tions, as well as contributed to the growth of Chinese HSS
research.
Second, the consistent increase in investments in vari-
ous healthcare fields enabled China to launch additional
health projects and provide funds to support Chinese re-
searchers in conducting high academic impact research.
For example, the National Natural Science Fund and the
Ministry of Health of China established health manage-
ment and policy category funds to support HSS research;
the financing amount for this program increases annually.
Third, the collaboration between China and other
countries or international institutions has become in-
creasingly frequent. The WHO, World Bank (WB) and
China Medical Board (CMB) provide training and funds
to Chinese researchers. For example, the WB/DFID
China Rural Health Project (2008 to 2013) is a typical
(and very large) program, which is funded by the
Chinese government, a WB loan and a grant from the
UK Department of International Development (DFID)
[65]. This project aims to provide experience and a
model for promoting rural health reform in areas in
China with different development levels. During this
process, WB and the UK government supplied financial
and technical/academic support for China. CMB also
supported Chinese researchers in universities to study
Fig. 7 Co-occurrence clustering map of author keywords (The size of the nodes indicates the frequency of the keywords, and the distance
between two nodes is inversely proportional to the number of co-occurrence between keywords, that is, shorter distances suggest greater co-
occurrence between keywords)
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health policy and system science-related fields [66].
These international activities and collaborations may
assist Chinese researchers to enhance their research
skills and publish additional international papers.
Chinese research evaluation policies also encourage
students to publish international papers. This case is
evident in the increasing number of universities requir-
ing additional staff members and doctoral and master’s
students to publish SCI/SSCI papers as one of their
requirements for graduation [67]. Therefore, the number
of international papers increased with the expansion of
graduate studies enrolment.
Collaboration between Chinese and foreign researchers is
becoming increasingly frequent
The collaboration trends between countries, institutions
and authors develop along with the publication growth
trends. Moreover, the cooperation of authors is evidently
higher than that of institutions and countries. Therefore,
Chinese research capacity and international influence in
HSS research may continue to strengthen. However, the
collaboration of authors is mostly conducted within
institutions or countries. The collaboration of China
with over two countries in one paper is still infrequent.
Given that productivity and are positively related to
extent and patterns of collaboration s, Chinese re-
searchers should improve the extent of collaboration
with foreign countries and institutions, particularly with
developed countries and well-known institutions.
Collaboration and performance with core partners and
institutions
China’s leading partners in HSS research are developed
countries, with the quantity of papers resulting from
cooperation with the US and the UK leading the way.
The academic impact of papers is also generally high for
European countries, such as Switzerland, the Netherlands
and others. Therefore, international collaboration with
these partners could improve the academic impact of
Chinese HSS research output. Hence, international collab-
oration is still necessary for China to enhance its HSS
research capacity. Meanwhile, the quantity of papers
resulting in cooperation with Asian countries is relatively
low, and the academic impact of these papers also needs
improvement. The aforementioned situation can also be
observed in the analysis of collaboration networks; hence,
developed countries have conducted considerable research
in this field with China.
This finding is consistent with parallel findings regard-
ing regular scientific research, which is positively corre-
lated with the level of economic development [68]. As a
developing country with a rapidly expanding economy in
the last 15 years, China’s strategy to solve its domestic
health problems involves utilizing its high output in the
health reform domain and cooperating with several
developed countries for its health reform needs. There-
fore, China could strengthen its collaboration relation-
ship with the aforementioned countries to improve the
academic impact of research. In this process, Chinese
researchers could also learn advanced methods and
valuable experience.
The concentration of HSS research in China is primar-
ily based in universities. Among the top 20 institutions
in this field, 17 are universities and the remaining 3 are
R&D organizations. A few elite Chinese institutions,
including CUHK, University of Hong Kong, Peking
University and Fudan University, contributed approxi-
mately half of the Chinese studies and have collaborated
with many international institutions. Additionally, the
collaboration between the institutions of Mainland
China and Hong Kong was frequent and close; however,
the international collaboration of the former’s institu-
tions was weaker than that of latter’s. Moreover, the
papers published by China’s Ministry of Health have a
relatively high academic impact because it is a trusted
source of information, and most of the ministry’s papers
were developed in collaboration with the US and the
UK. However, papers from Mainland China are consid-
ered low academic impact papers. Mainland China merely
has seven institutions, whereas numerous Hong Kong
institutions play an important role in Chinese HSS re-
search. Therefore, Mainland China’s institutions should
consider strengthening their collaborations with renowned
institutions in the HSS field.
Popular research topics are associated with China’s
healthcare reforms
The analysis of keywords shows that popular Chinese
health reform-centered topics were studied during the
last decades. In spite of its extensive range, HSS research
in China relatively focuses on healthcare reform, priority
diseases (e.g., breast cancer, HIV/AIDS, tuberculosis,
schistosomiasis, etc.), health systems performance, QOL
and measurement tools, palliative or end-of-life care, old
people problems, research methods and other related
topics, particularly those associated to China. These
topics drew significant attention from researchers and
policymakers.
Healthcare system reform in China has been the most
important topic during the last 30 years, particularly
after the latest reform in 2009. China’s healthcare system
reform has achieved major milestones, particularly in
health insurance, under the government’s leadership.
However, further analysis of the popular topics of the
related articles highlighted gaps and challenges that
need to be addressed to achieve China’s stated reform
goals. First, despite the extensive achievement in the
coverage of health insurance in China, particularly the
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New Cooperative and Medical Scheme (NCMS) and
Urban Resident Basic Medical Insurance (URBMI),
the effects of health insurance on the reduction of
financial risks is still unclear [69–72]. Second, al-
though the objective of the pharmaceutical sector to
control drugs is correct, the methods and the effect-
iveness of such methods are unclear [73, 74] and rela-
tively little has been published in this area. Third,
human resources shortage exists in China; hence, this
problem is a major obstacle in strengthening the pub-
lic health and primary health care of the country
[75]. In addition, retaining qualified health profes-
sionals in the rural areas, particularly in the poor and
underdeveloped regions, has been difficult because of
socioeconomic reasons and the lack of a proper
healthcare infrastructure [3]. Even with the availability
of staff members, the lack of incentives (e.g., higher
wages, work benefits, paid vacations, etc.) for primary
healthcare workers to deliver public health services
may be the main hindrance in retaining healthcare
human resources in the rural areas. Fourth, reforming
public hospitals is one of the key issues in controlling
the increase in healthcare expenditures, improvement
in the academic impact of care, and reduction of
waste and inefficient work performance [3]. The re-
form of public hospitals, particularly county and city
government hospitals, needs significant attention and
considerable effort to improve the academic impact of
service delivery. Finally, health services systems (including
provision and utilization) in China are disorganized, and
the referral systems and the function orientation of differ-
ent types of hospitals are still unclear. Relatively little has
been published on these important topics to date, so
these fields may be important frontiers for future
Chinese HSS research.
Conclusions
This study shows the publication trends, collaboration
patterns and research foci of HSS research in China
form multiple perspectives and levels. These results
could assist both Chinese and foreign researchers,
decision-makers and students understand the collabor-
ation networks, select research themes and determine
their partners in HSS research. Therefore, policymakers
and researchers could foster a promising type of inter-
national collaboration network and improve the research
performance for HSS research related to China.
Appendix 1
The history and milestone of Chinese healthcare reforms
from 1980 to 2015
In the past decades, healthcare reforms were the major
issues in China. Various policies adopted by health pol-
icymakers indicate that China’s healthcare system reform
passed through three periods [46] classified as follows:
(1) 1980s to 1993: market participation; (2) 1994–2005:
market orientation (profound marketization); and (3)
2006 to present: government-driven market involvement.
Numerous milestone events also happened during these
periods. For example, China’s healthcare system reform
began from the early 1980s to 1985. This period was
regarded as the first stage of the reforms because the
government officially approved the implementation of
the healthcare sector reform. Healthcare financing was
transferred from the central government to the local
governments. In 1990, many discussions were conducted
focusing on the dominant actor that should supervise
the implementation of the healthcare system reform.
This implementation was determined by the central
government that set the main principles for “market
participation” in 1992. In 1994, China began to reduce
expenditures in the healthcare system. In 1997, the
Chinese government encouraged the healthcare market
to become market-oriented. In 2000, the privatization of
several hospitals was allowed, thereby resulting in the
emergence of many private hospitals since then. In 2006,
health officials and decision-makers realized that the
previous reform was unsuccessful; thus, they imple-
mented a new round of reforms [4, 5]. In April 2009,
China unveiled its new healthcare reform plan with the
provisional goal of providing affordable and equitable
basic health care for all by 2020 [3, 7]. This reform was
anchored on five interdependent aspects: expanding
healthcare coverage to over 90 % of the population,
establishing a national essential medicine system to meet
all the citizens’ primary needs for medicine, improving
primary care delivery system to provide basic health care
and to manage referrals to hospitals’ specialists, making
public health services available and equitable to all, and
steering public hospitals reforms [7, 76, 77]. Before an-
nouncing the new healthcare system reform, the Chinese
government was faced with widespread public discontent
that stemmed from the following factors: unaffordable
access to health care, major financial risks associated
with out-of-pocket health expenditures, and growing
inequalities in accessing healthcare and health services
across populations with different socioeconomic status,
as well as between urban and rural areas [78–83]. Mean-
while, a few of the previously eradicated infectious
diseases had re-emerged, whereas non-communicable
diseases (NCDs) increased unabatedly [84–86]. In 2003,
the SARS outbreak shocked China’s leaders, thereby
exposing the inadequacies in the public health protec-
tion system and demonstrating government negligence
that had left the health system unprepared to deal
with its core responsibilities [2, 3]. Hence, examining
the reform priorities against the problems and their
causes in the pre-reform system led health authorities
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to determine that the current reforms are consider-
ably headed in the right direction. The next phase of
reforms, which was announced in detail in 2012 and
2013, intended to further improve the 2009 reforms
[87, 88]. The 2015 health reform focuses on promot-
ing government hospital reform (including county and
city hospitals), thereby improving the universal health
insurance system, strengthening the essential medications
system, improving the pharmaceutical supply system,
promoting an equitable primary public health services,
establishing hierarchical medical systems and referral
mechanisms, establishing proper health worker training
and wage payment systems, promoting the development
of the health services industry, and accelerating the devel-
opment of population health information systems [89].
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
LY and QY initiated and designed this study. QY participated in the study
design, collected the data, conducted the data analysis and wrote the
manuscript. KC, QY, JS, ZFH and ZYL contributed to the data analysis and the
revision of the manuscript. All authors were involved in data interpretation
and have read and given their final approval of this paper.
Authors’ information
Kai Chen (KC) M.P.H, Ph.D., is a candidate in School of Medicine and Health
Management, Tongji Medical College, Huazhong University of Science and
Technology, and deputy director of Division of Rural Health, Department of
Primary Health, National Health and Family Planning Commision of the
People’s Republic of China. His academic interests focus on health policy and
rural health.
Qiang Yao (QY) B.S, Ph.D., is a lecturer in the School of Political Science and
Public Administration of Wuhan University. His academic interests are in
health economics, health policy and systems, health services research and
scientometrics.
Ju Sun (JS) M.Ec, Ph.D., is an associate professor and deputy director of the
Department of Public Administration Management, School of Political
Science and Public Administration of Wuhan University. Her academic
interests are in health policy, health economics, health security, social welfare
and population health.
Zhi-fei He (ZFH) M.Sc, Ph.D., is a candidate in the School of Medicine and
Health Management, Tongji Medical College, Huazhong University of Science
and Technology. Her academic interests are in health policy and rural health.
Lan Yao (LY), M.P.H, Ph.D., is a professor in the School of Medicine and
Health Management, Tongji Medical College, Huazhong University of Science
and Technology, and executive director of the Chinese Basic Medical
Security Research Center, Huazhong University of Science & Technology. Her
academic interests focus on health economics and policy, medical security,
community healthcare service, rural healthcare.
Zhi-yong Liu (ZYL), M.S, Ph.D., is an associate professor in the School of
Medicine and Health Management, Tongji Medical College, Huazhong
University of Science and Technology. His academic interests focus on health
service research, hospital information management, health statistics.
Acknowledgments
We offer our sincere appreciation of the assistance of the Centre for Health
Statistics Information, Ministry of Health, People’s Republic of China. We also
acknowledge the reviewers and editors for their valuable comments.
Funding sources
There were no external funding sources.
Author details
1School of Medicine and Health Management, Tongji Medical College,
Huazhong University of Science and Technology, Wuhan, Hubei 430030,
China. 2School of Political Science and Public Administration, Wuhan
University, Wuhan, Hubei 430072, People’s Republic of China.
Received: 28 April 2015 Accepted: 19 January 2016
References
1. National Health and Family Planning Commission of People’s Republic of
China. China Health Statistics Yearbook 2013. Beijing: Peking Union Medical
College Press; 2013.
2. Li L, Chen Q, Powers D. Chinese healthcare reform a shift toward social
development. Mod Chin. 2012;38:630–45.
3. Yip WC, Hsiao WC, Chen W, Hu S, Ma J, Maynard A. Early appraisal of
China’s huge and complex health-care reforms. Lancet. 2012;379:833–42.
4. Around the “Chinese medical reform” of ups and downs in the six inflection
point. Oe Weekly (Focus) 2009:20–23.
5. Inventory of Chinese medical reform 30 years (1980–2013). J Med Inform.
2013;34:96.
6. Hu R, Shen C, Zou H-f. Health Care System Reform in China: Issues,
Challenges and Options. In: China Economics and Management Academy,
Central University of Finance and Economics. 2011.
7. Chen Z. Launch of the health-care reform plan in China. Lancet. 2009;
373:1322–4.
8. Chang HW, Huang MH. Prominent institutions in international collaboration
network in astronomy and astrophysics. Scientometrics. 2013;97:443–60.
9. Zhou P, Zhong YF, Yu MG. A bibliometric investigation on China-UK
collaboration in food and agriculture. Scientometrics. 2013;97:267–85.
10. Lee S, Bozeman B. The impact of research collaboration on scientific
productivity. Soc Stud Sci. 2005;35:673–702.
11. Hicks D. How much is a collaboration worth? A calibrated bibliometric
model. Scientometrics. 1997;40:541–54.
12. Ordonez-Matamoros G. International research collaboration, research team
performance, and scientific & technological capabilities in Colombia—a
bottom-up perspective. ProQuest; 2008.
13. Wagner-Döbler R. Continuity and discontinuity of collaboration
behaviour since 1800—from a bibliometric point of view.
Scientometrics. 2001;52:503–17.
14. Narin F, Whitlow E. Measurement of Scientific Cooperation and
Coauthorship in CEC-related Areas of Science (Office for Official Publications
of the European Communities, Luxembourg, Report EUR 12900). 1990.
15. Glänzel W. National characteristics in international scientific co-authorship
relations. Scientometrics. 2001;51:69–115.
16. Wagner CS, Leydesdorff L. Network structure, self-organization, and
the growth of international collaboration in science. Res Policy. 2005;
34:1608–18.
17. Wei H. A bilateral comparison of research performance at an institutional
level. Scientometrics. 2015;104:147–73.
18. Yao Q, Lyu PH, Yang LP, Yao L, Liu ZY. Current performance and future
trends in health care sciences and services research. Scientometrics.
2014;101:751–79.
19. Yao Q, Lyu PH, Ma FC, Yao L, Zhang SJ. Global informetric perspective
studies on translational medical research. BMC Med Inform Decis Mak.
2013;13:77.
20. Chen W, Chen S, Qi DC, Gao XY, Wee ATS. Surface transfer p-type doping of
epitaxial graphene. J Am Chem Soc. 2007;129:10418–22.
21. Yang L, Chen ZL, Liu T, Wan R, Wang J, Xie WG. Research output
analysis of municipal solid waste: a case study of China. Scientometrics.
2013;96:641–50.
22. Stefenon VM, Roesch LFW, Pereira AB. Thirty years of Brazilian research in
Antarctica: ups, downs and perspectives. Scientometrics. 2013;95:325–31.
23. Ren JL, Lyu PH, Wu XM, Ma FC, Wang ZZ, Yang G. An informetric
profile of water resources management literatures. Water Resour Manag.
2013;27:4679–96.
24. Mori H, Nakayama T. Academic Impact of Qualitative Studies in Healthcare:
Bibliometric Analysis. Plos One. 2013;8(3):e57371.
25. Diekhoff T, Schlattmann P, Dewey M. Impact of article language in
multi-language medical journals - a bibliometric analysis of self-citations
and impact factor. Plos One. 2013;8(10):e76816.
26. Bajwa RS, Yaldram K. Bibliometric analysis of biotechnology research in
Pakistan. Scientometrics. 2013;95:529–40.
Chen et al. Israel Journal of Health Policy Research  (2016) 5:1 Page 13 of 15
27. Rosas SR, Kagan JM, Schouten JT, Slack PA, Trochim WMK. Evaluating
research and impact: a bibliometric analysis of research by the NIH/NIAID
HIV/AIDS clinical trials networks. Plos One. 2011;6(3):e17428.
28. Chen YC, Wu JC, Haschler I, Majeed A, Chen TJ, Wetter T. Academic impact
of a public electronic health database: bibliometric analysis of studies using
the general practice research database. Plos One. 2011;6(6):e21404.
29. Bajwa RS, Yaldram K, Rafique S. A scientometric assessment of research
output in nanoscience and nanotechnology: Pakistan perspective.
Scientometrics. 2013;94:333–42.
30. Mahapatra M. On the validity of the theory of exponential growth of
scientific literature. In: Proceedings of the 15th IASLIC conference,
Bangalore. 1985. p. 61–70.
31. Yao Q, Chen K, Yao L, Lyu PH, Yang TA, Luo F, et al. Scientometric trends
and knowledge maps of global health systems research. Health Res Policy
Syst. 2014;12:26.
32. Cooper C. Revisiting coauthor responsibility. Science. 2003;299:511.
33. Lucio-Arias D, Leydesdorff L. Main-path analysis and path-dependent
transitions in HistCite (TM)-based historiograms. J Am Soc Inf Sci Technol.
2008;59:1948–62.
34. Borgatti SP, Everett MG, Freeman LC. Ucinet for Windows: Software for
social network analysis. 2002.
35. van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program
for bibliometric mapping. Scientometrics. 2010;84:523–38.
36. Ramakrishnan J, Thavamani K. Growth of literature in the field of Hepatitis-C.
Libr Philos Pract..2013.
37. Gopalakrishnan S, Natarajan M, Ramesh Babu B. Mapping of nanoscience
and nanotechnology research in India: a scientometric analysis, 1990-2009.
Scientometrics. 2011;89:501–22.
38. Rousseau R. Social network analysis: a powerful strategy, also for the
information sciences. J Inf Sci. 2002;28:441.
39. Wu Y, Duan Z. Social network analysis of international scientific
collaboration on psychiatry research. Int J Ment Health Syst. 2015;9:2.
40. Bornmann L, Leydesdorff L. Topical connections between the institutions
within an organisation (institutional co-authorships, direct citation links and
co-citations). Scientometrics. 2015;102:455–63.
41. Han P, Shi J, Li X, Wang D, Shen S, Su X. International collaboration in LIS:
global trends and networks at the country and institution level.
Scientometrics. 2014;98:53–72.
42. Cao X, Huang Y, Wang J, Luan S. Research status and trends in
limnology journals: a bibliometric analysis based on SCI database.
Scientometrics. 2012;92:735–46.
43. Garfield E. Citation indexing for studying science. Nature. 1970;227:669–71.
44. Yao Q, Chen J, Lyu PH, Zhang SJ, Ma FC, Fang JG. Knowledge map of
artemisinin research in SCI and Medline database. J Vector Borne Dis. 2012;
49:205–16.
45. Li LL, Ding GH, Feng N, Wang MH, Ho YS. Global stem cell research trend:
Bibliometric analysis as a tool for mapping of trends from 1991 to 2006.
Scientometrics. 2009;80:39–58.
46. Li L, Jiang Y, Chen Q. A review of China’s health care reform after the
reform and open policy in 1978. Chin Health Econ. 2008;27:5–9.
47. WHOQOL group. The World Health Organization quality of life assessment
(WHOQOL): position paper from the World Health Organization. Soc Sci
Med. 1995;41:1403–9.
48. Wu J, Han Y, Zhao FL, Zhou J, Chen Z, Sun H. Validation and comparison of
EuroQoL-5 dimension (EQ-5D) and Short Form-6 dimension (SF-6D) among
stable angina patients. Health Qual Life Outcomes. 2014;12:156.
49. Chen Y, Hicks A, While AE. Quality of life and related factors: a questionnaire
survey of older people living alone in Mainland China. Qual Life Res. 2014;
23:1593–602.
50. Li J, Yuan L, Wu Y, Luan Y, Hao Y. The Chinese version of the Pediatric Quality
Of Life Inventory (PedsQL) healthcare satisfaction generic module (version 3.0):
psychometric evaluation. Health Qual Life Outcomes. 2013;11:113.
51. Cui J, Fang F, Shen F, Song L, Zhou L, Ma X, et al. Quality of Life in
Patients With Advanced Cancer at the End of Life as Measured by the
McGill Quality of Life Questionnaire: A Survey in China. J Pain Symptom
Manage. 2014;48:893–902.
52. Wong AH, Tsang HW, Li SM, Fung KM, Chung RC, Leung AY, et al.
Development and initial validation of Perceived Rehabilitation Needs
Questionnaire for people with schizophrenia. Qual Life Res. 2011;20:447–56.
53. Chou KL, Leung JC. Disability trends in Hong Kong community-dwelling
Chinese older adults: 1996, 2000, and 2004. J Aging Health. 2008;20:385–404.
54. Chou KL. The prevalence and clustering of four major lifestyle risk factors in
Hong Kong Chinese older adults. J Aging Health. 2008;20:788–803.
55. Liu S, Yam CH, Huang OH, Griffiths SM. Willingness to pay for private
primary care services in Hong Kong: are elderly ready to move from the
public sector? Health Policy Plan. 2013;28:717–29.
56. Lo RS, Kwan BH, Lau KP, Kwan CW, Lam LM, Woo J. The needs, current
knowledge, and attitudes of care staff toward the implementation of
palliative care in old age homes. Am J Hosp Palliat Care. 2010;27:266–71.
57. Lau KS, Tse DM, Tsan Chen TW, Lam PT, Lam WM, Chan KS. Comparing
noncancer and cancer deaths in Hong Kong: a retrospective review. J Pain
Symptom Manage. 2010;40:704–14.
58. Tse DM, Chan KS, Lam WM, Leu K, Lam PT. The impact of palliative care on
cancer deaths in Hong Kong: a retrospective study of 494 cancer deaths.
Palliat Med. 2007;21:425–33.
59. Yong DS, Kwok AO, Wong DM, Suen MH, Chen WT, Tse DM.
Symptom burden and quality of life in end-stage renal disease: a
study of 179 patients on dialysis and palliative care. Palliat Med.
2009;23:111–9.
60. Lam TP, Khoo US, Chan YS, Cheng YH, Lam KF. The first batch of graduates
of a new medical curriculum in Asia: how their teachers see them. Med
Educ. 2004;38:980–6.
61. Lam WW, Fielding R, Johnston JM, Tin KY, Leung GM. Identifying barriers to
the adoption of evidence-based medicine practice in clinical clerks: a
longitudinal focus group study. Med Educ. 2004;38:987–97.
62. Johnston JM, Leung GM, Fielding R, Tin KY, Ho LM. The development and
validation of a knowledge, attitude and behaviour questionnaire to assess
undergraduate evidence-based practice teaching and learning. Med Educ.
2003;37:992–1000.
63. Jin ZC, Wu C, Zhou XH, He J. A modified regression method to test
publication bias in meta-analyses with binary outcomes. BMC Med Res
Methodol. 2014;14:132.
64. Tang JL, Liu JL. Misleading funnel plot for detection of bias in meta-analysis.
J Clin Epidemiol. 2000;53:477–84.
65. Foreign-funded project for China rural health [http://www.chinadaily.com.
cn/m/chinahealth/2014-11/25/content_18975576.htm].
66. Health Policy and Systems Sciences [http://chinamedicalboard.org/
programs/health-policy-and-systems-sciences].
67. The Requirement of Graduate Students’ Publications for Doctor’s or
Master’s degrees Application [http://oec.ujs.edu.cn/uploads/cms/201511/
28/FB28072827988496.pdf].
68. Vinkler P. Correlation between the structure of scientific research,
scientometric indicators and GDP in EU and non-EU countries.
Scientometrics. 2008;74:237–54.
69. Yip W, Hsiao WC. Non-evidence-based policy: how effective is China’s new
cooperative medical scheme in reducing medical impoverishment? Soc Sci
Med. 2009;68:201–9.
70. Lei X, Lin W. The New Cooperative Medical Scheme in rural China: does
more coverage mean more service and better health? Health Econ. 2009;18
Suppl 2:S25–46.
71. Wagstaff A, Lindelow M. Can insurance increase financial risk?: The curious
case of health insurance in China. J Health Econ. 2008;27:990–1005.
72. Meng Q, Xu L, Zhang Y, Qian J, Cai M, Xin Y, et al. Trends in access to
health services and financial protection in China between 2003 and 2011:
a cross-sectional study. Lancet. 2012;379:805–14.
73. Ministry of Health of the People’s Republic of China. Report on the
implementation of national essential medicines policies. Beijing: Ministry of
Health; 2011.
74. Guan X, Liang H, Xue Y, Shi L. An analysis of China’s national essential
medicines policy. J Public Health Policy. 2011;32:305–19.
75. Liu Q, Wang B, Kong Y, Cheng KK. China’s primary health-care reform.
Lancet. 2011;377:2064–6.
76. Current major project on health care system reform (2009–2011).
http://www.gov.cn/test/2009-04/08/content_1280057.htm (published
Apr 8, 2009, accessed Dec 8, 2013). [http://www.moh.gov.cn/zwgkzt/
pzcqgh/201204/7d5a2d6f9f2548a4a43652a2e63a7e1e.shtml]
77. Communist Party of China Central Committee: State Council. National
Development and Reform Commission Web site. Opinions of the CPC
Central Committee and the State Council on deepening the health care
system reform, March 17, 2009. 2009.
78. Blumenthal D, Hsiao W. Privatization and its discontents—the evolving
Chinese health care system. N Engl J Med. 2005;353:1165–70.
Chen et al. Israel Journal of Health Policy Research  (2016) 5:1 Page 14 of 15
79. Hu S, Tang S, Liu Y, Zhao Y, Escobar M-L, de Ferranti D. Reform of how
health care is paid for in China: challenges and opportunities. Lancet.
2008;372:1846–53.
80. Liu Y, Rao K, Wu J, Gakidou E. China’s health system performance. The
Lancet. 2008;372:1914–23.
81. Tang S, Meng Q, Chen L, Bekedam H, Evans T, Whitehead M. Tackling the
challenges to health equity in China. Lancet. 2008;372:1493–501.
82. Yip W, Hsiao WC. The Chinese health system at a crossroads. Health Affairs.
2008;27:460–8.
83. Yip WC-M, Hsiao W, Meng Q, Chen W, Sun X. Realignment of incentives for
health-care providers in China. Lancet. 2010;375:1120–30.
84. Wang L, Kong L, Wu F, Bai Y, Burton R. Preventing chronic diseases in China.
Lancet. 2005;366:1821–4.
85. Wang L, Wang Y, Jin S, Wu Z, Chin DP, Koplan JP, et al. Emergence and
control of infectious diseases in China. Lancet. 2008;372:1598–605.
86. Yang G, Kong L, Zhao W, Wan X, Zhai Y, Chen LC, et al. Emergence of
chronic non-communicable diseases in China. Lancet. 2008;372:1697–705.
87. State Council of People’s Republic of China: Opinions of the State Council
on deepening the health care system reform main work arrangements in
2012. http://www.gov.cn/zwgk/2012-04/18/content_2115928.htm
(published Apr 14, 2012, accessed Dec 8, 2013). 2012.
88. State Council of People’s Republic of China: Opinions of the State Council
on deepening the health care system reform main work arrangements in
2013. http://www.moh.gov.cn/tigs/s7846/201307/
e32ef659410449baa79808a00849eb91.shtml (published Jul 18, 2012,
accessed Dec 8, 2013). 2013.
89. National Health and Family Planning Commission on the issuance of 2015
points of health planning work [http://www.moh.gov.cn/bgt/s7692/201501/
e804c7cc6e8d4c5d924f4109acc9b45e.shtml].
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Chen et al. Israel Journal of Health Policy Research  (2016) 5:1 Page 15 of 15
